← Back to Search

Cardiovascular Health Awareness Program for Cardiovascular Risk

N/A
Waitlist Available
Led By Gina Agarwal
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 1 year
Awards & highlights

Study Summary

This trial will improve the cardiovascular health of seniors living in subsidized housing by implementing the successful community-based Cardiovascular Health Awareness Program (CHAP).

Eligible Conditions
  • Cardiovascular Risk
  • Cardiovascular Disease
  • Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Healthcare Utilization Composite - Change in CVD-related emergency department visits and hospitalizations
Secondary outcome measures
Change in quality of life
Cost-effectiveness
Healthcare Utilization - Change in all-cause emergency department visits
+3 more
Other outcome measures
Cardiovascular Risk - Change in blood pressure
Cardiovascular Risk - Change in body mass index
Cardiovascular Risk - Change in diabetes risk score
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CHAP InterventionExperimental Treatment1 Intervention
The Cardiovascular Health Awareness Program (CHAP) intervention is an on-site drop-in, monthly, cardiovascular risk assessment program run by trained volunteers with community-led group health sessions that deliver education and information about access to community health resources. The education sessions will be delivered by national and provincial and local community organizations utilizing already developed material as much as possible, but maintaining consistency across both provinces. Health education sessions will include topics such as: Physical Activity, Healthy Eating, Stress, Tobacco Use, High Blood Pressure, Role of Pharmacist: How they can assist people, and Appropriate use of 9-1-1. This intervention will be held in a common room in selected subsidized housing buildings.
Group II: ControlActive Control1 Intervention
The control buildings will receive usual care which will be wellness programs already present in the building prior to the RCT if these are present. Not all control buildings will have wellness programs.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cardiovascular Health Awareness Program
2018
N/A
~2750

Find a Location

Who is running the clinical trial?

McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,595,086 Total Patients Enrolled
1 Trials studying Cardiovascular Risk
5 Patients Enrolled for Cardiovascular Risk
Université de MontréalOTHER
213 Previous Clinical Trials
99,979 Total Patients Enrolled
Gina AgarwalPrincipal InvestigatorMcMaster University
1 Previous Clinical Trials
79 Total Patients Enrolled

Frequently Asked Questions

~417 spots leftby Apr 2025